(Q53762221)
Statements
Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative Group (English)
M González Barón
J Feliu
E Espinosa
C García Girón
E Blanco
P Garrido
A Colmenarejo
A Ordóñez
A Moyano
I de la Gándara